These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8666574

  • 1. Medication optimization during clozapine treatment.
    Suppes T, Rush AJ.
    J Clin Psychiatry; 1996 Jul; 57(7):307-8. PubMed ID: 8666574
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
    Allen L, Tejera C.
    Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
    Dodt JE, Byerly MJ, Cuadros C, Christensen RC.
    Am J Psychiatry; 1997 Apr; 154(4):582. PubMed ID: 9090357
    [No Abstract] [Full Text] [Related]

  • 4. Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
    Rahman MS, Grace JJ, Pato MT, Priest B.
    Am J Psychiatry; 1998 Nov; 155(11):1629-30. PubMed ID: 9812137
    [No Abstract] [Full Text] [Related]

  • 5. Sertraline and mental retardation with obsessive-compulsive disorder.
    Wiener K, Lamberti JS.
    Am J Psychiatry; 1993 Aug; 150(8):1270. PubMed ID: 8328577
    [No Abstract] [Full Text] [Related]

  • 6. Panic attacks precipitated by sertraline.
    Zinner SH.
    Am J Psychiatry; 1994 Jan; 151(1):147-8. PubMed ID: 8267115
    [No Abstract] [Full Text] [Related]

  • 7. Sertraline-induced akathisia.
    LaPorta LD.
    J Clin Psychopharmacol; 1993 Jun; 13(3):219-20. PubMed ID: 8354739
    [No Abstract] [Full Text] [Related]

  • 8. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
    Koran LM, Mueller K, Maloney A.
    J Clin Psychopharmacol; 1996 Jun; 16(3):253-4. PubMed ID: 8784659
    [No Abstract] [Full Text] [Related]

  • 9. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [Abstract] [Full Text] [Related]

  • 10. Valproate pretreatment for the difficult-to-treat patient with OCD.
    Deltito JA.
    J Clin Psychiatry; 1994 Nov; 55(11):500. PubMed ID: 7989288
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin reuptake blockers for the treatment of obsessional jealousy.
    Stein DJ, Hollander E, Josephson SC.
    J Clin Psychiatry; 1994 Jan; 55(1):30-3. PubMed ID: 8294389
    [Abstract] [Full Text] [Related]

  • 12. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M, Englisch S, Knopf U, Kuwilsky A, Dressing H.
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract] [Full Text] [Related]

  • 13. Sertraline in the treatment of neurotic excoriations and related disorders.
    Kalivas J, Kalivas L, Gilman D, Hayden CT.
    Arch Dermatol; 1996 May; 132(5):589-90. PubMed ID: 8624163
    [No Abstract] [Full Text] [Related]

  • 14. High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
    Byerly MJ, Goodman WK, Christensen R.
    Am J Psychiatry; 1996 Sep; 153(9):1232-3. PubMed ID: 8780435
    [No Abstract] [Full Text] [Related]

  • 15. Inability to cry during SRI treatment.
    Oleshansky MA, Labbate LA.
    J Clin Psychiatry; 1996 Dec; 57(12):593. PubMed ID: 9010124
    [No Abstract] [Full Text] [Related]

  • 16. [Response to sertraline in adolescents with obsessive-compulsive disorder].
    Rodríguez-Ramos P, Mardomingo Sanz MJ.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 Dec; 26(1):17-21. PubMed ID: 9549132
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of transvestic fetishism with sertraline and lithium.
    Rubenstein EB, Engel NL.
    J Clin Psychiatry; 1996 Feb; 57(2):92. PubMed ID: 8591978
    [No Abstract] [Full Text] [Related]

  • 18. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D, McTavish D.
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [Abstract] [Full Text] [Related]

  • 19. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    Chouinard G.
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW, Morton WA, Lydiard RB.
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.